Table 2. Characteristics of patients and clinics included in analyses during the three time periods, EuroSIDA study, 2004–05, 2009–10 and 2014–15.
| 2004–05 | 2009–10 | 2014–15 | ||||
|---|---|---|---|---|---|---|
| Number of clinics included | 96 | 100 | 105 | |||
| Total number of patients included | 8,743 | 10,013 | 12,825 | |||
| Median number of patients per clinic, n (IQR) | 74 (39–114) | 90 (49–136) | 108 (64–167) | |||
| Age in years, median (IQR) | 40.9 (35.6–47.8) | 44.9 (37.8–51.8) | 48.3 (39.9–54.7) | |||
| n | % | n | % | n | % | |
| Sex | ||||||
| Male | 6,543 | 74.8 | 7,257 | 72.5 | 9,352 | 72.9 |
| Female | 2,200 | 25.2 | 2,756 | 27.5 | 3,473 | 27.1 |
| Region of residence | ||||||
| Western Europe | 2,137 | 24.4 | 2,385 | 23.8 | 3,033 | 23.6 |
| Southern Europe | 2,586 | 29.6 | 2,420 | 24.2 | 2,957 | 23.1 |
| Northern Europe | 2,218 | 25.4 | 2,319 | 23.2 | 2,902 | 22.6 |
| East Central Europe | 975 | 11.2 | 1,409 | 14.1 | 1,934 | 15.1 |
| Eastern Europe | 827 | 9.5 | 1,480 | 14.8 | 1,999 | 15.6 |
| Mode of infection | ||||||
| MSM | 3,692 | 42.2 | 4,143 | 41.4 | 4,772 | 37.2 |
| PWID | 2,053 | 23.5 | 2,087 | 20.8 | 3,363 | 26.2 |
| Heterosexual | 2,432 | 27.8 | 3,084 | 30.8 | 3,750 | 29.2 |
| Other/unknown | 566 | 6.5 | 699 | 7.0 | 940 | 7.3 |
| Number of patients on ART, % of total | 5,928 | 67.8 | 7,687 | 76.8 | 10,034 | 78.2 |
| By mode of infection, % of risk group | ||||||
| MSM | 2,774 | 75.1 | 3,364 | 81.2 | 3,845 | 80.6 |
| PWID | 1,171 | 57.0 | 1,421 | 68.1 | 2,439 | 72.5 |
| Heterosexual | 1,560 | 64.1 | 2,347 | 76.1 | 2,997 | 79.9 |
| Other/unknown | 423 | 74.7 | 555 | 79.4 | 753 | 80.1 |
| Patients not receiving ART with CD4+ T-cell count < 200 cells/mL, % of those not on ART | 405 | 14.4 | 192 | 8.3 | 280 | 10.0 |
| By region of residence, % of those not on ART in that region | ||||||
| Western Europe | 81 | 13.0 | 36 | 6.7 | 75 | 9.8 |
| Southern Europe | 92 | 14.4 | 32 | 7.0 | 44 | 5.5 |
| Northern Europe | 98 | 19.4 | 18 | 6.4 | 13 | 3.6 |
| East Central Europe | 66 | 19.4 | 20 | 6.7 | 34 | 11.8 |
| Eastern Europe | 68 | 9.6 | 86 | 11.4 | 114 | 20.0 |
| Patients with missing information on HIV RNA among those on ART, % of total on ART | 188 | 3.2 | 455 | 5.9 | 758 | 7.6 |
| Patients with HIV RNA < 500 copies/mL among those on ART, % of total on ART | 4,460 | 75.2 | 6,777 | 88.2 | 8,803 | 87.7 |
| By mode of infection, % of risk group on ART | ||||||
| MSM | 2,136 | 77.0 | 3,107 | 92.4 | 3,523 | 91.6 |
| PWID | 861 | 73.5 | 1,135 | 79.9 | 1,976 | 81.0 |
| Heterosexual | 1,152 | 73.8 | 2,036 | 86.7 | 2,631 | 87.8 |
| Other/unknown | 311 | 73.5 | 499 | 89.9 | 673 | 89.4 |
ART: antiretroviral treatment; IQR: interquartile range; MSM: men who have sex with men; PWID: people who inject drugs.